Skip to main content
Browse by Title
Browse by Category
Browse by Presenter
Browse by Number
Browse by Day and Session
Award Recipients
Newsworthy Abstracts
Outstanding Poster Presenters
ePoster Wall Gallery
Toggle navigation
Search
Home
Browse by Title
Browse by Category
Browse by Presenter
Browse by Number
Browse by Day and Session
Award Recipients
Newsworthy Abstracts
Outstanding Poster Presenters
ePoster Wall Gallery
Back
Like
Email
Tweet this
Millie Long, MD, MPH, FACG
UNC Chapel Hill
Poster(s):
C0400 - Early Symptom Control With Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis in the LUCENT-1 Induction Trial
Monday, October 24, 2022
3:00 PM – 5:00 PM
ET
C0401 - Sustained Symptom Control With Mirikizumab in Patients With Moderately-to-Severely Active Ulcerative Colitis in the LUCENT-2 Maintenance Trial
Monday, October 24, 2022
3:00 PM – 5:00 PM
ET
C0402 - Efficacy of Upadacitinib Dose Escalation in a Phase 3 Long-Term Extension Ulcerative Colitis Study
Monday, October 24, 2022
3:00 PM – 5:00 PM
ET
Email Millie
